Eric Weisblum - 15 Dec 2025 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Weisblum
Issuer symbol
SILO
Transactions as of
15 Dec 2025
Net transactions value
+$2,075
Form type
4
Filing time
16 Dec 2025, 18:34:59 UTC
Previous filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weisblum Eric Chief Executive Officer, Director C/O SILO PHARMA, INC., 677 N. WASHINGTON BOULEVARD, SARASOTA /s/ Eric Weisblum 16 Dec 2025 0001569077

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILO Common Stock Purchase $1,025 +2,500 +1.2% $0.4100 214,432 15 Dec 2025 Direct
transaction SILO Common Stock Purchase $1,050 +2,500 +1.2% $0.4200 216,932 15 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.